Search Results - "L'Azou Jackson, Maïna"

Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization by Patel, Minal K., Bergeri, Isabel, Bresee, Joseph S., Cowling, Benjamin J., Crowcroft, Natasha S., Fahmy, Kamal, Hirve, Siddhivinayak, Kang, Gagandeep, Katz, Mark A., Lanata, Claudio F., L'Azou Jackson, Maïna, Joshi, Sudhir, Lipsitch, Marc, Mwenda, Jason M., Nogareda, Francisco, Orenstein, Walter A., Ortiz, Justin R., Pebody, Richard, Schrag, Stephanie J., Smith, Peter G., Srikantiah, Padmini, Subissi, Lorenzo, Valenciano, Marta, Vaughn, David W., Verani, Jennifer R., Wilder-Smith, Annelies, Feikin, Daniel R.

“…Phase 3 randomized-controlled trials have provided promising results of COVID-19 vaccine efficacy, ranging from 50 to 95% against symptomatic disease as the…”
Get full text

Projecting vaccine demand and impact for emerging zoonotic pathogens by Lerch, Anita, Ten Bosch, Quirine A, L'Azou Jackson, Maïna, Bettis, Alison A, Bernuzzi, Mauro, Murphy, Georgina A V, Tran, Quan M, Huber, John H, Siraj, Amir S, Bron, Gebbiena M, Elliott, Margaret, Hartlage, Carson S, Koh, Sojung, Strimbu, Kathyrn, Walters, Magdalene, Perkins, T Alex, Moore, Sean M

“…Despite large outbreaks in humans seeming improbable for a number of zoonotic pathogens, several pose a concern due to their epidemiological characteristics…”
Get full text

Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens by Yimer, Solomon Abebe, Booij, Birgitte Boonstra, Tobert, Gwen, Hebbeler, Andrew, Oloo, Paul, Brangel, Polina, L'Azou Jackson, Maïna, Jarman, Richard, Craig, Danielle, Avumegah, Michael Selorm, Mandi, Henshaw, Endy, Timothy, Wooden, Stacey, Clark, Carolyn, Bernasconi, Valentina, Shurtleff, Amy, Kristiansen, Paul A

“…Rapid diagnostic tests (RDTs) are critical for preparedness and response against an outbreak or pandemic and have been highlighted in the 100 Days Mission, a…”
Get full text

The global epidemiology of chikungunya from 1999 to 2020: A systematic literature review to inform the development and introduction of vaccines by Bettis, Alison A, L'Azou Jackson, Maïna, Yoon, In-Kyu, Breugelmans, J Gabrielle, Goios, Ana, Gubler, Duane J, Powers, Ann M

“…Chikungunya fever is an acute febrile illness that is often associated with severe polyarthralgia in humans. The disease is caused by chikungunya virus…”
Get full text

Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021 by Gerken, Keli N, LaBeaud, A Desirée, Mandi, Henshaw, L'Azou Jackson, Maïna, Breugelmans, J Gabrielle, King, Charles H

“…Rift Valley fever virus (RVFV) is a lethal threat to humans and livestock in many parts of Africa, the Arabian Peninsula, and the Indian Ocean. This systematic…”
Get full text

Medical countermeasures against henipaviruses: a review and public health perspective by Gómez Román, Raúl, Tornieporth, Nadia, Cherian, Neil George, Shurtleff, Amy C, L’Azou Jackson, Maïna, Yeskey, Debra, Hacker, Adam, Mungai, Eric, Le, Tung Thanh

“…Henipaviruses, including Nipah virus, are regarded as pathogens of notable epidemic potential because of their high pathogenicity and the paucity of specific…”
Get full text

Rural prioritization may increase the impact of COVID-19 vaccines in a representative COVAX AMC country setting due to ongoing internal migration: A modeling study by Selvaraj, Prashanth, Wagner, Bradley G, Chao, Dennis L, Jackson, Maïna L'Azou, Breugelmans, J Gabrielle, Jackson, Nicholas, Chang, Stewart T

“…How COVID-19 vaccine is distributed within low- and middle-income countries has received little attention outside of equity or logistical concerns but may…”
Get full text

Rural prioritization may increase the impact of COVID-19 vaccines in a representative COVAX AMC country setting due to ongoing internal migration: A modeling study by Prashanth Selvaraj, Bradley G Wagner, Dennis L Chao, Maïna L'Azou Jackson, J Gabrielle Breugelmans, Nicholas Jackson, Stewart T Chang

“…How COVID-19 vaccine is distributed within low- and middle-income countries has received little attention outside of equity or logistical concerns but may…”
Get full text